Savitz Ryan — SEC insider filings
SEC reporting owner CIK 1992324. 11 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-26 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 6 filings — 317,882 shares, $26,220,910 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
- Largest priced transaction: sale of 58,396 shares @ $90.90 ($5,308,196) in Dianthus Therapeutics, Inc. /DE/, filed 2026-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | 11 | — | 23 legs · 317,882 sh · $26,220,910 | 37 |
Insider filings — Savitz Ryan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 29,276 @ $17.88 · Option exercise (M): 20,608 @ $21.77 · Option exercise (M): 40,430 @ $22.07 · Option exercise (M): 10,399 @ $8.44 · Sale (S): 300 @ $85.16 · Sale (S): 700 @ $86.70 · +23 more | EDGAR |
| 2026-07-13 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 31,249 @ $21.77 · Sale (S): 10,354 @ $100.22 · Sale (S): 15,329 @ $101.24 · Sale (S): 5,566 @ $101.97 · Option exercise (M): 31,249 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 8,224 @ $17.88 · Sale (S): 8,224 @ $89.84 · Option exercise (M): 8,224 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 74,367 @ $8.44 · Option exercise (M): 40,000 @ $17.88 · Sale (S): 1,390 @ $78.33 · Sale (S): 21,825 @ $78.86 · Sale (S): 1,485 @ $80.25 · Sale (S): 800 @ $81.36 · +6 more | EDGAR |
| 2026-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 20,000 @ $8.44 · Sale (S): 20,000 @ $45.18 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-09-25 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 20,000 @ $8.44 · Sale (S): 20,000 @ $35 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1992324 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs